Tonix Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Highlights
ValueSpectrum,
On track to submit NDA in the second half of 2024 for Tonmya™ for fibromyalgia; pre-NDA meeting with FDA scheduled for second…
On track to submit NDA in the second half of 2024 for Tonmya™ for fibromyalgia; pre-NDA meeting with FDA scheduled for second…
On track to submit NDA in the second half of 2024 for Tonmya™ for fibromyalgia; pre-NDA meeting with FDA scheduled for second…
On track to submit NDA in the second half of 2024 for Tonmya for fibromyalgia; pre-NDA meeting with FDA scheduled for second…
On track to submit NDA in the second half of 2024 for Tonmya™ for fibromyalgia; pre-NDA meeting with FDA scheduled for second…